ArticleBMC pregnancy and childbirth2025
The association between mean arterial pressure and memory decline in preeclampsia patients: a mediation analysis of serum amyloid-β 1-42 and phosphorylated tau 181.
Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundPreeclampsia (PE) can damage the central nervous system of pregnant women, leading to a decline in cognitive function, and this effect can persist for several decades after childbirth. Amyloid-β 1-42 (Aβ1-42) had neurotoxicity and excessive deposition can damage neural synapses. Excessive production of phosphorylated tau 181 (P-tau181) can reduce the transport efficiency of axons in nerve cells, leading to degeneration of nerve cell protrusions and cell death. The aim of our study was to compare memory function status and serum Aβ1-42 and P-tau181 levels in PE patients and healthy controls to explore the related factors affecting memory function in PE patients and the possible pathogenic mechanism leading to the decline in memory function.
methodsOne hundred and fifteen PE patients, forty-eight nonpregnant healthy controls (NPHCs) and forty-seven pregnant healthy controls (PHCs) were included. The clinical data of each participants, included blood pressure, were collected. Neurological examinations and neuropsychological tests effectively evaluate all participants' memory status. Among these, the Auditory Verbal Learning Test-Huashan Version (AVLT-H) is particularly useful. The levels of serum Aβ1-42 and P-tau181 were detected by enzyme linked immunosorbent assay. The associations between the mean arterial pressure (MAP), total AVLT-H score and serum Aβ1-42 and P-tau181 levels were investigated by mediation analysis. The contribution ratio of each factor affecting the total AVLT-H score was obtained by principal component analysis.
resultsThere were obvious differences in the total AVLT-H score and the levels of serum Aβ1-42 and P-tau181 among the PE patients and healthy controls (p < 0.05). Mediation analysis revealed that the MAP affected the total AVLT-H score in three ways. The principal component analysis showed that the main factors affecting memory function were the serum Aβ1-42 and P-tau181 levels and the MAP, in that order of contribution.
conclusionsThese findings highlight that the elevated blood pressure can lead to decreased memory function in PE patients through the mediating effect of serum Aβ1-42 and P-tau181 levels. Blood pressure monitoring and early detection of memory decline should be strictly and regularly carried out in PE patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.